2 Articles
![A row of filing cabinets](https://anderson-review.ucla.edu/wp-content/uploads/2023/11/AR-thumb-cancer-trials.png)
Huge Spending — But Little Sharing of Research Results — on Cancer Drugs
U.S. efforts to encourage transparency widely ignored by companies
![FDA building](https://anderson-review.ucla.edu/wp-content/uploads/2020/08/AR-fda-flexibility-hero-760x570.jpg)
A Tool to Make FDA Drug Approval Practices Transparent
Researchers aim to help the agency, drug companies and patients better understand the complex authorization process